LBRA: Buy Low, Sell High
1847 Holdings announces sale of largest portfolio operation $65 million in cash, representing sales multiples of 1.6 times revenue and 7.5 times operating income as reported. Proceeds from sale of…
LBRA: New Stock Symbol as Acquisition Portfolio Expands
1847 Holdings scores success in its acquisition portfolio, as revenue soars and profits emerge; full year 2025 revenue of $48 million and $4.0 million in operating profits. Plan pending to…
Cloudastructure: proprietary security services with AI tech
Cloudastructure among first movers using artificial intelligence (AI) technology in an innovative site security application Proprietary site security solution delivering impressive results in terms of effective threat identification and intervention…
Our Bond: AI Driven Personal Security Solution
Spot on market timing for new security services as global tensions rise and local communities experience rising theft and assault rates Proprietary suite of personal security services using a mobile…
Context Therapeutics: Undervalued Cancer Fighter
Portfolio of three novel immunological therapies based on bispecific T-cell engager technology, each with differentiating performance against multiple cancersEnrollment initiated in first half 2025 for Phase I clinical trials for…
Clearmind Medicine: Exploring a Pathway out of Alcohol Abuse
Clearmind Medicine (CMND) is a clinical stage pharmaceutical company with the promising CMND-100 candidate at the front end of its pipeline. CMND-100 is based on the psychoactive compound MEAI, shorthand for the synthetic molecule…